Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: J Hypertens. 2022 Aug 23;40(10):2037–2044. doi: 10.1097/HJH.0000000000003228

Table 1. Participant characteristics and clinical measures stratified by blood pressure devices.

Variables Device 1 (n = 171) Device 2 (n = 52) P values
Participant characteristics
    Male sex [n (%)] 119 (70) 43 (83) 0.063
    CAD [n (%)] 111 (65) 42 (81) 0.031
    Age (years) 60 ± 10 62 ± 10 0.446
    Weight (kg) 86.8 ± 18.8 92.8 ± 13.4 0.037
    Height (cm)a 170.8 ± 9.4 173.9 ± 10.9 0.052
    BMI (kg/m2) 29.7 ± 5.3 30.6 ± 3.7 0.270
    eGFR (ml/min per 1.73 m2) 89.5 ± 25.9 83.9 ± 24.3 0.169
Noninvasive measures (mmHg)
    Estimated aortic SBP 119 ± 16 127 ± 18 0.002
    Cuff brachial SBP 131 ± 18 133 ± 17 0.489
    Estimated SBP amplification 12 ±4 6 ± 4 <0.001
    Cuff heart rate (bpm) 66 ± 12 65 ± 12 0.508
Invasive measures (mmHg)
    Aortic SBP 130 ± 21 128 ± 21 0.715
    Brachial SBP 138 ± 21 136 ± 20 0.554
    SBP amplification 8 ± 8 8 ± 7 0.542
    Aortic heart rate (bpm) 64 ± 12 66 ± 11 0.307
    Aortic Alx (%) 23.2 ± 20.0 25.2 ± 17.8 0.519
    Brachial Alx (%) –14 ± 20.6 1.0 ± 16.2 0.437

Sphygmocor Xcel and Uscom BP+ were defined as device 1 and device 2. respectively.Data are mean ± standard deviation or n (%).SBP amplification = brachial SBP - aortic SBP; PP amplification = brachial PP - aortic PP.AIx. augmentation index; eGFR, estimated glomerular filtration rate: PP. pulse pressure; SBP. systolic blood pressure.

a

Height data were available in n = 164 (Xcel device) and n = 40 (BP+ device) due to missing.